JJ Case Continued: [NEW INFORMATION]: JJ was started on an ophthalmic prostaglandin analog after her first visit and has been compliant with therapy. At her 3 month follow-up visit her IOP has not yet reached the desired goal in her right eye. She does not have any additional new medical conditions. She and her eye care provider agree the next step will be to try dual pharmacologic therapy by adding_an agent with a different mechanism of action. Which is the most appropriate new ophthalmic therapy to add to her prior therapy at this time? a. netarsudil (Rhopressa) b. methazolamide oral C. timolol (Timoptic) d. dorzolamide (Trusopt) brimonidine (Alphagan P) e.
JJ Case Continued: [NEW INFORMATION]: JJ was started on an ophthalmic prostaglandin analog after her first visit and has been compliant with therapy. At her 3 month follow-up visit her IOP has not yet reached the desired goal in her right eye. She does not have any additional new medical conditions. She and her eye care provider agree the next step will be to try dual pharmacologic therapy by adding_an agent with a different mechanism of action. Which is the most appropriate new ophthalmic therapy to add to her prior therapy at this time? a. netarsudil (Rhopressa) b. methazolamide oral C. timolol (Timoptic) d. dorzolamide (Trusopt) brimonidine (Alphagan P) e.
Chapter7: Drug Sources, Schedules, And Dosages
Section: Chapter Questions
Problem 16RQ
Related questions
Question
![**JJ Case Continued: [NEW INFORMATION]**:
**JJ was started on an ophthalmic prostaglandin analog** after her first visit and has been compliant with therapy. At her 3 month follow-up visit her IOP has not yet reached the desired goal in her right eye. She does not have any additional new medical conditions.
She and her eye care provider agree the next step will be to try dual pharmacologic therapy **by adding an agent with a different mechanism of action.**
**Which is the most appropriate new ophthalmic therapy to add to her prior therapy at this time?**
- a. netarsudil (Rhopressa)
- b. methazolamide oral
- c. timolol (Timoptic)
- d. dorzolamide (Trusopt)
- e. brimonidine (Alphagan P)](/v2/_next/image?url=https%3A%2F%2Fcontent.bartleby.com%2Fqna-images%2Fquestion%2F4886508f-4429-44bc-b69f-0f40b6686249%2Ffe363506-3da3-4fd1-89b7-4521f62aa055%2F1spgett_processed.jpeg&w=3840&q=75)
Transcribed Image Text:**JJ Case Continued: [NEW INFORMATION]**:
**JJ was started on an ophthalmic prostaglandin analog** after her first visit and has been compliant with therapy. At her 3 month follow-up visit her IOP has not yet reached the desired goal in her right eye. She does not have any additional new medical conditions.
She and her eye care provider agree the next step will be to try dual pharmacologic therapy **by adding an agent with a different mechanism of action.**
**Which is the most appropriate new ophthalmic therapy to add to her prior therapy at this time?**
- a. netarsudil (Rhopressa)
- b. methazolamide oral
- c. timolol (Timoptic)
- d. dorzolamide (Trusopt)
- e. brimonidine (Alphagan P)
Expert Solution
![](/static/compass_v2/shared-icons/check-mark.png)
This question has been solved!
Explore an expertly crafted, step-by-step solution for a thorough understanding of key concepts.
Step by step
Solved in 3 steps
![Blurred answer](/static/compass_v2/solution-images/blurred-answer.jpg)
Recommended textbooks for you
Understanding Health Insurance: A Guide to Billin…
Health & Nutrition
ISBN:
9781337679480
Author:
GREEN
Publisher:
Cengage
Understanding Health Insurance: A Guide to Billin…
Health & Nutrition
ISBN:
9781337679480
Author:
GREEN
Publisher:
Cengage